French pharmaceutical company Sanofi has appointed Paul Hudson as the company’s new CEO. The 51-year-old Brit is currently working as a director at Swiss rival Novartis and will take over from Oliver Brandicourt on September 1, who will retire. Hudson has been at the helm of the pharmaceutical division of Novartis since 2016. Previously he also worked a decade for the British AstraZeneca. Brandicourt, who has been in charge of Sanofi since April 2015, announced earlier that he will retire. The search for a successor took several weeks.